Zhijian Liu
About
Zhijian Liu has authored 23 papers that have received a total of 536 indexed citations.
This includes 15 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oral Surgery. The topics of these papers are RNA modifications and cancer (5 papers), Protein Tyrosine Phosphatases (3 papers) and MicroRNA in disease regulation (3 papers). Zhijian Liu is often cited by papers focused on RNA modifications and cancer (5 papers), Protein Tyrosine Phosphatases (3 papers) and MicroRNA in disease regulation (3 papers) and collaborates with scholars based in China and Hong Kong. Zhijian Liu's co-authors include Hong He, Mingyuan Du, Yunlong Wang, Feng Sun and Zhengguo Cao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Molecular Cancer.
In The Last Decade
Fields of papers published by Zhijian Liu
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries citing papers authored by Zhijian Liu
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Shuai Fang Breakdown of academic impact, for papers by Rebecca Preston Breakdown of academic impact, for papers by Abbas M. Lafta Breakdown of academic impact, for papers by Anna Klepacz-Smółka Breakdown of academic impact, for papers by Chenyang Yu Breakdown of academic impact, for papers by Wenke Wang Breakdown of academic impact, for papers by Tadahiro Murakami Breakdown of academic impact, for papers by Susanne Jäger